Health ❯ Healthcare ❯ Pharmaceuticals ❯ Drug Development

Immune Checkpoint Inhibitors

ctDNA-Guided Atezolizumab Extends Survival After Bladder Cancer Surgery in Phase III Trial

Regulators will now evaluate linking immunotherapy use to a ctDNA companion test.